Establishment of a Rat Model for Renal Anemia Based on 5/6 Nephrectomized Rats

Area of Science:

• Nephrology
• Hematology
• Pharmacology

Background:

• Chronic kidney disease (CKD) leads to renal fibrosis and anemia, impacting quality of life and cardiovascular health.
• Renal anemia in CKD stems from reduced erythropoietin (EPO) production and disrupted iron metabolism.
• Chronic renal failure (CRF) anemia presents significant clinical challenges.

Purpose of the Study:

• To develop and validate an experimental model for CRF-associated anemia using a 5/6 nephrectomy (Nx) rat model.
• To investigate the effects of tacrolimus (TAC) on exacerbating renal injury and anemia in the Nx model.
• To provide a preclinical platform for studying CKD/CRF-related anemia mechanisms and evaluating therapies.

Main Methods:

• Male Wistar rats underwent 5/6 nephrectomy (Nx) to induce CKD.
• Tacrolimus (TAC) was administered to a subset of Nx rats to worsen renal injury.
• Renal function, hematological parameters, iron indices, and fibrosis were assessed postoperatively.

Main Results:

• Nx rats exhibited progressive renal dysfunction, fibrosis, declining hematocrit, and reduced EPO levels.
• TAC administration aggravated renal injury and anemia, causing lower hematocrit despite detectable EPO.
• Findings suggest a relative erythropoietic response inadequacy rather than absolute EPO deficiency in advanced injury.

Conclusions:

• The Nx model effectively replicates key features of CKD-associated anemia.
• TAC addition accelerates disease progression, creating an advanced renal injury model.
• This system serves as a practical preclinical tool for therapeutic development targeting CKD anemia.